Last $2.34 USD
Change Today -0.01 / -0.43%
Volume 215.2K
CYTX On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

E. Carmack Holmes M.D.

Director and Member of Governance & Nominating Committee, Cytori Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 60 board members in 2 different organizations across 2 different industries.

See Board Relationships
75$83,233

Background*

Dr. E. Carmack Holmes, MD served as the Surgeon-in-Chief of the University of California Los Angeles (UCLA) Medical Center since 1994 and holds the position of William P. Longmire, Jr. Professor and Chairman of Department of Surgery at UCLA School of Medicine. Dr. Holmes joined UCLA in 1973 and has held professorial positions in the Divisions of Cardiothoracic Surgery and Surgical Oncology for over 30 years. Dr. Holmes served as Vice Chairman of UCLA for five years prior ...

Read Full Background

Corporate Headquarters*

3020 Callan Road
San Diego, California 92121

United States

Phone: 858-458-0900
Fax: 858-458-0994

Board Members Memberships*

Director
2003-Present
Director and Member of Governance & Nominating Committee

Education*

Unknown/Other Education
Duke University
MD
University of North Carolina

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$41,000
Total Calculated Compensation$83,233
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYTX:US $2.34 USD -0.01

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Gil Van Bokkelen Ph.D.Co-Founder, Chairman and Chief Executive Officer
Athersys, Inc.
$568.8K
Michael D. West Ph.D.Chief Executive Officer, President and Director
BioTime, Inc.
$760.5K
Robin L. Smith M.D., MBA,RoExecutive Chairman and Chief Executive Officer
Neostem, Inc.
$945.0K
Edward H. Myles MBAPrincipal Executive Officer, Interim President, Chief Financial Officer, Principal Accounting Officer and Executive Vice President of Corporate Development
Advanced Cell Technology Inc.
--
Zami Aberman Executive Chairman and Chief Executive Officer
Pluristem Therapeutics, Inc.
$544.2K
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYTORI THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.